Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB2 | P30411 | 4/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3723663 | 1.00 | BDKRB2 (0.51) | BDKRB2HTR2AHTR2CHTR2BALDH1A1 | |
| SCHEMBL15301082 | 0.95 | BDKRB2 (0.47) | BDKRB2HTR2AHTR2CHTR2BALDH1A1 | |
| SCHEMBL6656944 | 0.95 | BDKRB2 (0.47) | BDKRB2HTR2AHTR2CHTR2BALDH1A1 | |
| SCHEMBL14353644 | 0.86 | BDKRB2 (0.56) | BDKRB2HTR2AHTR2CHTR2BCYP1A2 | |
| SCHEMBL28163233 | 0.86 | BDKRB2 (0.56) | BDKRB2HTR2AHTR2CHTR2BCYP1A2 | |
| SCHEMBL28033428 | 0.86 | BDKRB2 (0.45) | BDKRB2TDP1CYP3A4CYP1A2CYP2A6 | |
| SCHEMBL16807625 | 0.84 | BDKRB2 (0.41) | BDKRB2HTR2AHTR2CHTR2BALDH1A1 | |
| SCHEMBL153634 | 0.83 | BDKRB2 (0.48) | BDKRB2ALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL28033478 | 0.82 | BDKRB2 (0.40) | BDKRB2ALDH1A1CYP3A4TSHRCA2 | |
| SCHEMBL20342362 | 0.82 | BDKRB2 (0.40) | BDKRB2HTR2AHTR2CHTR2BALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070141747-A1 | Electronic device fabrication process | XEROX CORPORATION | 2007-06-21 | — | — | US | claimed |
| EP-1433211-B1 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES CO (US) | 2006-06-21 | — | — | EP | claimed |
| US-6864396-B2 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-08 | — | — | US | claimed |
| EP-1433211-A2 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M Innovative Properties Company (US) | 2004-06-30 | — | — | EP | claimed |
| US-20030105365-A1 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY | 2003-06-05 | — | — | US | claimed |
| WO-2003028125-A2 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-04-03 | — | — | WO | claimed |
| US-7651885-B2 | Electronic device fabrication process | XEROX CORPORATION (US) | 2010-01-26 | — | — | US | disclosed |
| US-20070141747-A1 | Electronic device fabrication process | XEROX CORPORATION | 2007-06-21 | — | — | US | disclosed |
| EP-1433211-B1 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES CO (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20050288522-A1 | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES COMPANY | 2005-12-29 | — | — | US | disclosed |
| US-6974877-B2 | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-12-13 | — | — | US | disclosed |
| US-6864396-B2 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-08 | — | — | US | disclosed |
| EP-1433211-A2 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M Innovative Properties Company (US) | 2004-06-30 | — | — | EP | disclosed |
| US-20030105365-A1 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY | 2003-06-05 | — | — | US | disclosed |
| US-20030100779-A1 | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-29 | — | — | US | disclosed |
| WO-2003028125-A2 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288522-A1 | Process for preparing pentacene derivatives | RARA, RARB, C9 | BDKRB2 1711/4885HTR2A 532/4885HTR2C 1540/4885 |
| US-20030105365-A1 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | ETV1, HTR3C, SLC43A1 | BDKRB2 4037/4885HTR2A 92/4885HTR2C 48/4885 |
| US-20030100779-A1 | Process for preparing pentacene derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PCBP1, RARA | BDKRB2 2386/4885HTR2A 851/4885HTR2C 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.